nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—KDM4C—brain cancer	0.0057	0.0773	CbGpPWpGaD
Cyproterone acetate—Medroxyprogesterone Acetate—CYP2C9—brain cancer	0.00401	1	CrCbGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—OTX2—brain cancer	0.00396	0.0537	CbGpPWpGaD
Cyproterone acetate—Coma—Carmustine—brain cancer	0.00358	0.00388	CcSEcCtD
Cyproterone acetate—Neoplasm—Carmustine—brain cancer	0.00354	0.00384	CcSEcCtD
Cyproterone acetate—Gynaecomastia—Carmustine—brain cancer	0.00351	0.0038	CcSEcCtD
Cyproterone acetate—Cardiovascular disorder—Etoposide—brain cancer	0.00345	0.00374	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Lomustine—brain cancer	0.00345	0.00374	CcSEcCtD
Cyproterone acetate—Neoplasm—Temozolomide—brain cancer	0.00342	0.00371	CcSEcCtD
Cyproterone acetate—Abnormal vision—Carmustine—brain cancer	0.00342	0.00371	CcSEcCtD
Cyproterone acetate—Jaundice—Procarbazine—brain cancer	0.00341	0.0037	CcSEcCtD
Cyproterone acetate—Sweating—Procarbazine—brain cancer	0.00336	0.00364	CcSEcCtD
Cyproterone acetate—Anorexia—Lomustine—brain cancer	0.00335	0.00364	CcSEcCtD
Cyproterone acetate—Skin discolouration—Etoposide—brain cancer	0.00335	0.00364	CcSEcCtD
Cyproterone acetate—Haematuria—Procarbazine—brain cancer	0.00334	0.00362	CcSEcCtD
Cyproterone acetate—Abnormal vision—Temozolomide—brain cancer	0.0033	0.00358	CcSEcCtD
Cyproterone acetate—Phlebitis—Carmustine—brain cancer	0.0033	0.00358	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Hydroxyurea—brain cancer	0.0033	0.00357	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Carmustine—brain cancer	0.00329	0.00356	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Carmustine—brain cancer	0.00327	0.00355	CcSEcCtD
Cyproterone acetate—Body temperature increased—Carboplatin—brain cancer	0.00318	0.00345	CcSEcCtD
Cyproterone acetate—Breast disorder—Hydroxyurea—brain cancer	0.00318	0.00345	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Temozolomide—brain cancer	0.00318	0.00344	CcSEcCtD
Cyproterone acetate—Haemoglobin—Procarbazine—brain cancer	0.00316	0.00343	CcSEcCtD
Cyproterone acetate—Haemorrhage—Procarbazine—brain cancer	0.00314	0.00341	CcSEcCtD
Cyproterone acetate—Decreased appetite—Lomustine—brain cancer	0.00306	0.00332	CcSEcCtD
Cyproterone acetate—Hepatic failure—Temozolomide—brain cancer	0.00306	0.00332	CcSEcCtD
Cyproterone acetate—Pancreatitis—Hydroxyurea—brain cancer	0.00298	0.00323	CcSEcCtD
Cyproterone acetate—Hot flush—Temozolomide—brain cancer	0.00294	0.00319	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Temozolomide—brain cancer	0.00291	0.00316	CcSEcCtD
Cyproterone acetate—Dermatitis exfoliative—Temozolomide—brain cancer	0.00291	0.00316	CcSEcCtD
Cyproterone acetate—Chills—Procarbazine—brain cancer	0.00282	0.00306	CcSEcCtD
Cyproterone acetate—Body temperature increased—Lomustine—brain cancer	0.00278	0.00302	CcSEcCtD
Cyproterone acetate—Alopecia—Procarbazine—brain cancer	0.00278	0.00301	CcSEcCtD
Cyproterone acetate—Weight increased—Hydroxyurea—brain cancer	0.00277	0.003	CcSEcCtD
Cyproterone acetate—Rash maculo-papular—Etoposide—brain cancer	0.00275	0.00299	CcSEcCtD
Cyproterone acetate—Affect lability—Temozolomide—brain cancer	0.00271	0.00293	CcSEcCtD
Cyproterone acetate—Tension—Procarbazine—brain cancer	0.00269	0.00291	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Carmustine—brain cancer	0.00263	0.00285	CcSEcCtD
Cyproterone acetate—Mood swings—Temozolomide—brain cancer	0.0026	0.00282	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00256	0.00278	CcSEcCtD
Cyproterone acetate—Phlebitis—Etoposide—brain cancer	0.00255	0.00277	CcSEcCtD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00254	0.0345	CbGpPWpGaD
Cyproterone acetate—Anaemia—Procarbazine—brain cancer	0.00253	0.00274	CcSEcCtD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00251	0.034	CbGpPWpGaD
Cyproterone acetate—Muscular weakness—Carmustine—brain cancer	0.00251	0.00272	CcSEcCtD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—HEY1—brain cancer	0.00249	0.0338	CbGpPWpGaD
Cyproterone acetate—Breast disorder—Temozolomide—brain cancer	0.00248	0.00269	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00247	0.00268	CcSEcCtD
Cyproterone acetate—Syncope—Procarbazine—brain cancer	0.00246	0.00266	CcSEcCtD
Cyproterone acetate—Leukopenia—Procarbazine—brain cancer	0.00245	0.00266	CcSEcCtD
Cyproterone acetate—Haemoglobin—Hydroxyurea—brain cancer	0.00245	0.00265	CcSEcCtD
Cyproterone acetate—Haemorrhage—Hydroxyurea—brain cancer	0.00243	0.00264	CcSEcCtD
Cyproterone acetate—Muscular weakness—Temozolomide—brain cancer	0.00242	0.00263	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00242	0.00263	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Procarbazine—brain cancer	0.00241	0.00261	CcSEcCtD
Cyproterone acetate—Cough—Procarbazine—brain cancer	0.00239	0.00259	CcSEcCtD
Cyproterone acetate—Sweating increased—Temozolomide—brain cancer	0.00231	0.00251	CcSEcCtD
Cyproterone acetate—Cardiac failure—Etoposide—brain cancer	0.00225	0.00244	CcSEcCtD
Cyproterone acetate—Vomiting—Lomustine—brain cancer	0.00224	0.00243	CcSEcCtD
Cyproterone acetate—Oedema—Procarbazine—brain cancer	0.00223	0.00242	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Carmustine—brain cancer	0.00222	0.0024	CcSEcCtD
Cyproterone acetate—Angiopathy—Hydroxyurea—brain cancer	0.00221	0.00239	CcSEcCtD
Cyproterone acetate—Shock—Procarbazine—brain cancer	0.0022	0.00238	CcSEcCtD
Cyproterone acetate—Pollakiuria—Temozolomide—brain cancer	0.00219	0.00238	CcSEcCtD
Cyproterone acetate—AR—FOXA1 transcription factor network—SHH—brain cancer	0.00219	0.0297	CbGpPWpGaD
Cyproterone acetate—Erectile dysfunction—Temozolomide—brain cancer	0.00219	0.00237	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Procarbazine—brain cancer	0.00219	0.00237	CcSEcCtD
Cyproterone acetate—Chills—Hydroxyurea—brain cancer	0.00218	0.00237	CcSEcCtD
Cyproterone acetate—Tachycardia—Procarbazine—brain cancer	0.00218	0.00236	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Temozolomide—brain cancer	0.00217	0.00235	CcSEcCtD
Cyproterone acetate—Weight increased—Temozolomide—brain cancer	0.00216	0.00234	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Procarbazine—brain cancer	0.00216	0.00234	CcSEcCtD
Cyproterone acetate—Renal failure—Carmustine—brain cancer	0.00215	0.00234	CcSEcCtD
Cyproterone acetate—Alopecia—Hydroxyurea—brain cancer	0.00215	0.00233	CcSEcCtD
Cyproterone acetate—Weight decreased—Temozolomide—brain cancer	0.00215	0.00233	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Temozolomide—brain cancer	0.00214	0.00232	CcSEcCtD
Cyproterone acetate—Anorexia—Procarbazine—brain cancer	0.00213	0.00231	CcSEcCtD
Cyproterone acetate—Nausea—Lomustine—brain cancer	0.00209	0.00227	CcSEcCtD
Cyproterone acetate—Hypotension—Procarbazine—brain cancer	0.00209	0.00226	CcSEcCtD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00206	0.028	CbGpPWpGaD
Cyproterone acetate—Hepatobiliary disease—Temozolomide—brain cancer	0.002	0.00217	CcSEcCtD
Cyproterone acetate—Haemoglobin—Carmustine—brain cancer	0.00198	0.00214	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptors—ESR2—brain cancer	0.00197	0.0267	CbGpPWpGaD
Cyproterone acetate—Haemorrhage—Carmustine—brain cancer	0.00197	0.00213	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Hydroxyurea—brain cancer	0.00197	0.00213	CcSEcCtD
Cyproterone acetate—Anaemia—Hydroxyurea—brain cancer	0.00196	0.00212	CcSEcCtD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—ESR2—brain cancer	0.00194	0.0264	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Procarbazine—brain cancer	0.00194	0.00211	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Etoposide—brain cancer	0.00194	0.0021	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Carmustine—brain cancer	0.00193	0.0021	CcSEcCtD
Cyproterone acetate—Fatigue—Procarbazine—brain cancer	0.00193	0.00209	CcSEcCtD
Cyproterone acetate—Haemoglobin—Temozolomide—brain cancer	0.00191	0.00207	CcSEcCtD
Cyproterone acetate—Malaise—Hydroxyurea—brain cancer	0.00191	0.00207	CcSEcCtD
Cyproterone acetate—Constipation—Procarbazine—brain cancer	0.00191	0.00207	CcSEcCtD
Cyproterone acetate—Haemorrhage—Temozolomide—brain cancer	0.0019	0.00206	CcSEcCtD
Cyproterone acetate—Hepatitis—Temozolomide—brain cancer	0.0019	0.00206	CcSEcCtD
Cyproterone acetate—Leukopenia—Hydroxyurea—brain cancer	0.0019	0.00206	CcSEcCtD
Cyproterone acetate—Visual impairment—Carmustine—brain cancer	0.0019	0.00206	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Temozolomide—brain cancer	0.00187	0.00203	CcSEcCtD
Cyproterone acetate—Sweating increased—Etoposide—brain cancer	0.00185	0.00201	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Procarbazine—brain cancer	0.00184	0.002	CcSEcCtD
Cyproterone acetate—Eye disorder—Carmustine—brain cancer	0.00184	0.00199	CcSEcCtD
Cyproterone acetate—Visual impairment—Temozolomide—brain cancer	0.00183	0.00199	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Procarbazine—brain cancer	0.00183	0.00198	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Temozolomide—brain cancer	0.0018	0.00195	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00179	0.00194	CcSEcCtD
Cyproterone acetate—Discomfort—Hydroxyurea—brain cancer	0.00178	0.00193	CcSEcCtD
Cyproterone acetate—Eye disorder—Temozolomide—brain cancer	0.00178	0.00193	CcSEcCtD
Cyproterone acetate—Urticaria—Procarbazine—brain cancer	0.00177	0.00192	CcSEcCtD
Cyproterone acetate—Abdominal pain—Procarbazine—brain cancer	0.00177	0.00192	CcSEcCtD
Cyproterone acetate—Body temperature increased—Procarbazine—brain cancer	0.00177	0.00192	CcSEcCtD
Cyproterone acetate—Alopecia—Carmustine—brain cancer	0.00174	0.00189	CcSEcCtD
Cyproterone acetate—Oedema—Hydroxyurea—brain cancer	0.00173	0.00187	CcSEcCtD
Cyproterone acetate—Angiopathy—Temozolomide—brain cancer	0.00173	0.00187	CcSEcCtD
Cyproterone acetate—Mental disorder—Carmustine—brain cancer	0.00172	0.00187	CcSEcCtD
Cyproterone acetate—Immune system disorder—Temozolomide—brain cancer	0.00172	0.00186	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Temozolomide—brain cancer	0.00171	0.00186	CcSEcCtD
Cyproterone acetate—Malnutrition—Carmustine—brain cancer	0.00171	0.00186	CcSEcCtD
Cyproterone acetate—Chills—Temozolomide—brain cancer	0.00171	0.00185	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Hydroxyurea—brain cancer	0.0017	0.00184	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Hydroxyurea—brain cancer	0.00169	0.00184	CcSEcCtD
Cyproterone acetate—Alopecia—Temozolomide—brain cancer	0.00168	0.00182	CcSEcCtD
Cyproterone acetate—Skin disorder—Hydroxyurea—brain cancer	0.00168	0.00182	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Etoposide—brain cancer	0.00167	0.00181	CcSEcCtD
Cyproterone acetate—Renal failure—Etoposide—brain cancer	0.00167	0.00181	CcSEcCtD
Cyproterone acetate—Mental disorder—Temozolomide—brain cancer	0.00167	0.00181	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Etoposide—brain cancer	0.00166	0.0018	CcSEcCtD
Cyproterone acetate—Malnutrition—Temozolomide—brain cancer	0.00166	0.00179	CcSEcCtD
Cyproterone acetate—Jaundice—Etoposide—brain cancer	0.00165	0.00179	CcSEcCtD
Cyproterone acetate—Anorexia—Hydroxyurea—brain cancer	0.00165	0.00179	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Procarbazine—brain cancer	0.00165	0.00178	CcSEcCtD
Cyproterone acetate—Asthenia—Procarbazine—brain cancer	0.0016	0.00174	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Etoposide—brain cancer	0.0016	0.00174	CcSEcCtD
Cyproterone acetate—Anaemia—Carmustine—brain cancer	0.00158	0.00172	CcSEcCtD
Cyproterone acetate—Pruritus—Procarbazine—brain cancer	0.00158	0.00171	CcSEcCtD
Cyproterone acetate—Agitation—Carmustine—brain cancer	0.00157	0.00171	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00156	0.0211	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Hydroxyurea—brain cancer	0.00154	0.00167	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Temozolomide—brain cancer	0.00154	0.00167	CcSEcCtD
Cyproterone acetate—Leukopenia—Carmustine—brain cancer	0.00153	0.00166	CcSEcCtD
Cyproterone acetate—Anaemia—Temozolomide—brain cancer	0.00153	0.00166	CcSEcCtD
Cyproterone acetate—Diarrhoea—Procarbazine—brain cancer	0.00153	0.00166	CcSEcCtD
Cyproterone acetate—Dyspepsia—Hydroxyurea—brain cancer	0.00152	0.00165	CcSEcCtD
Cyproterone acetate—Agitation—Temozolomide—brain cancer	0.00152	0.00165	CcSEcCtD
Cyproterone acetate—Decreased appetite—Hydroxyurea—brain cancer	0.0015	0.00163	CcSEcCtD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.0015	0.0204	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HES5—brain cancer	0.00149	0.0203	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—ESR2—brain cancer	0.00149	0.0203	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00149	0.00162	CcSEcCtD
Cyproterone acetate—Malaise—Temozolomide—brain cancer	0.00149	0.00162	CcSEcCtD
Cyproterone acetate—Fatigue—Hydroxyurea—brain cancer	0.00149	0.00162	CcSEcCtD
Cyproterone acetate—Leukopenia—Temozolomide—brain cancer	0.00148	0.00161	CcSEcCtD
Cyproterone acetate—Constipation—Hydroxyurea—brain cancer	0.00148	0.0016	CcSEcCtD
Cyproterone acetate—Dizziness—Procarbazine—brain cancer	0.00148	0.0016	CcSEcCtD
Cyproterone acetate—Cough—Temozolomide—brain cancer	0.00144	0.00157	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Etoposide—brain cancer	0.00144	0.00156	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Hydroxyurea—brain cancer	0.00142	0.00155	CcSEcCtD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CDK6—brain cancer	0.00142	0.0193	CbGpPWpGaD
Cyproterone acetate—Eye disorder—Etoposide—brain cancer	0.00142	0.00154	CcSEcCtD
Cyproterone acetate—Vomiting—Procarbazine—brain cancer	0.00142	0.00154	CcSEcCtD
Cyproterone acetate—Rash—Procarbazine—brain cancer	0.00141	0.00153	CcSEcCtD
Cyproterone acetate—Dermatitis—Procarbazine—brain cancer	0.00141	0.00153	CcSEcCtD
Cyproterone acetate—Headache—Procarbazine—brain cancer	0.0014	0.00152	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.0014	0.00152	CcSEcCtD
Cyproterone acetate—Oedema—Carmustine—brain cancer	0.0014	0.00152	CcSEcCtD
Cyproterone acetate—Discomfort—Temozolomide—brain cancer	0.00139	0.00151	CcSEcCtD
Cyproterone acetate—Angiopathy—Etoposide—brain cancer	0.00138	0.0015	CcSEcCtD
Cyproterone acetate—Immune system disorder—Etoposide—brain cancer	0.00137	0.00149	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Etoposide—brain cancer	0.00137	0.00149	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Carmustine—brain cancer	0.00137	0.00148	CcSEcCtD
Cyproterone acetate—Body temperature increased—Hydroxyurea—brain cancer	0.00137	0.00148	CcSEcCtD
Cyproterone acetate—Chills—Etoposide—brain cancer	0.00137	0.00148	CcSEcCtD
Cyproterone acetate—Tachycardia—Carmustine—brain cancer	0.00136	0.00148	CcSEcCtD
Cyproterone acetate—Oedema—Temozolomide—brain cancer	0.00135	0.00146	CcSEcCtD
Cyproterone acetate—Alopecia—Etoposide—brain cancer	0.00134	0.00146	CcSEcCtD
Cyproterone acetate—Anorexia—Carmustine—brain cancer	0.00133	0.00144	CcSEcCtD
Cyproterone acetate—Nausea—Procarbazine—brain cancer	0.00133	0.00144	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Temozolomide—brain cancer	0.00132	0.00144	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Temozolomide—brain cancer	0.00132	0.00143	CcSEcCtD
Cyproterone acetate—Skin disorder—Temozolomide—brain cancer	0.00131	0.00142	CcSEcCtD
Cyproterone acetate—Hypotension—Carmustine—brain cancer	0.00131	0.00142	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Temozolomide—brain cancer	0.00131	0.00142	CcSEcCtD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—HES1—brain cancer	0.00129	0.0175	CbGpPWpGaD
Cyproterone acetate—Anorexia—Temozolomide—brain cancer	0.00129	0.0014	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Hydroxyurea—brain cancer	0.00127	0.00138	CcSEcCtD
Cyproterone acetate—Dyspnoea—Carmustine—brain cancer	0.00125	0.00135	CcSEcCtD
Cyproterone acetate—Asthenia—Hydroxyurea—brain cancer	0.00124	0.00135	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Etoposide—brain cancer	0.00123	0.00133	CcSEcCtD
Cyproterone acetate—Anaemia—Etoposide—brain cancer	0.00122	0.00133	CcSEcCtD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.00122	0.0165	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Carmustine—brain cancer	0.00122	0.00132	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Carmustine—brain cancer	0.00121	0.00131	CcSEcCtD
Cyproterone acetate—Dyspnoea—Temozolomide—brain cancer	0.0012	0.00131	CcSEcCtD
Cyproterone acetate—Constipation—Carmustine—brain cancer	0.0012	0.0013	CcSEcCtD
Cyproterone acetate—Malaise—Etoposide—brain cancer	0.00119	0.0013	CcSEcCtD
Cyproterone acetate—Dyspepsia—Temozolomide—brain cancer	0.00119	0.00129	CcSEcCtD
Cyproterone acetate—Leukopenia—Etoposide—brain cancer	0.00119	0.00129	CcSEcCtD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—CDK4—brain cancer	0.00118	0.0161	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Hydroxyurea—brain cancer	0.00118	0.00128	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00118	0.016	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Temozolomide—brain cancer	0.00117	0.00127	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Temozolomide—brain cancer	0.00117	0.00126	CcSEcCtD
Cyproterone acetate—Fatigue—Temozolomide—brain cancer	0.00116	0.00126	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Etoposide—brain cancer	0.00116	0.00126	CcSEcCtD
Cyproterone acetate—Cough—Etoposide—brain cancer	0.00116	0.00125	CcSEcCtD
Cyproterone acetate—Constipation—Temozolomide—brain cancer	0.00116	0.00125	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Carmustine—brain cancer	0.00115	0.00125	CcSEcCtD
Cyproterone acetate—Dizziness—Hydroxyurea—brain cancer	0.00114	0.00124	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Carmustine—brain cancer	0.00114	0.00124	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HES5—brain cancer	0.00113	0.0154	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00112	0.00121	CcSEcCtD
Cyproterone acetate—Discomfort—Etoposide—brain cancer	0.00111	0.00121	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Temozolomide—brain cancer	0.00111	0.00121	CcSEcCtD
Cyproterone acetate—Abdominal pain—Carmustine—brain cancer	0.00111	0.0012	CcSEcCtD
Cyproterone acetate—Body temperature increased—Carmustine—brain cancer	0.00111	0.0012	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Temozolomide—brain cancer	0.0011	0.0012	CcSEcCtD
Cyproterone acetate—Vomiting—Hydroxyurea—brain cancer	0.0011	0.00119	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP2C9—brain cancer	0.00109	0.0149	CbGpPWpGaD
Cyproterone acetate—Rash—Hydroxyurea—brain cancer	0.00109	0.00118	CcSEcCtD
Cyproterone acetate—Dermatitis—Hydroxyurea—brain cancer	0.00109	0.00118	CcSEcCtD
Cyproterone acetate—Headache—Hydroxyurea—brain cancer	0.00108	0.00117	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP2C9—brain cancer	0.00108	0.0146	CbGpPWpGaD
Cyproterone acetate—Urticaria—Temozolomide—brain cancer	0.00107	0.00116	CcSEcCtD
Cyproterone acetate—Abdominal pain—Temozolomide—brain cancer	0.00107	0.00116	CcSEcCtD
Cyproterone acetate—Body temperature increased—Temozolomide—brain cancer	0.00107	0.00116	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Etoposide—brain cancer	0.00106	0.00115	CcSEcCtD
Cyproterone acetate—Tachycardia—Etoposide—brain cancer	0.00105	0.00114	CcSEcCtD
Cyproterone acetate—Skin disorder—Etoposide—brain cancer	0.00105	0.00114	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Etoposide—brain cancer	0.00104	0.00113	CcSEcCtD
Cyproterone acetate—Anorexia—Etoposide—brain cancer	0.00103	0.00112	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Carmustine—brain cancer	0.00103	0.00112	CcSEcCtD
Cyproterone acetate—Nausea—Hydroxyurea—brain cancer	0.00103	0.00111	CcSEcCtD
Cyproterone acetate—Hypotension—Etoposide—brain cancer	0.00101	0.0011	CcSEcCtD
Cyproterone acetate—Asthenia—Carmustine—brain cancer	0.001	0.00109	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Temozolomide—brain cancer	0.000995	0.00108	CcSEcCtD
Cyproterone acetate—Asthenia—Temozolomide—brain cancer	0.000969	0.00105	CcSEcCtD
Cyproterone acetate—Dyspnoea—Etoposide—brain cancer	0.000964	0.00104	CcSEcCtD
Cyproterone acetate—Diarrhoea—Carmustine—brain cancer	0.000956	0.00104	CcSEcCtD
Cyproterone acetate—Pruritus—Temozolomide—brain cancer	0.000956	0.00104	CcSEcCtD
Cyproterone acetate—Decreased appetite—Etoposide—brain cancer	0.00094	0.00102	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Etoposide—brain cancer	0.000933	0.00101	CcSEcCtD
Cyproterone acetate—Fatigue—Etoposide—brain cancer	0.000932	0.00101	CcSEcCtD
Cyproterone acetate—Dizziness—Carmustine—brain cancer	0.000924	0.001	CcSEcCtD
Cyproterone acetate—Constipation—Etoposide—brain cancer	0.000924	0.001	CcSEcCtD
Cyproterone acetate—Diarrhoea—Temozolomide—brain cancer	0.000924	0.001	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000922	0.0125	CbGpPWpGaD
Cyproterone acetate—Dizziness—Temozolomide—brain cancer	0.000893	0.000969	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Etoposide—brain cancer	0.000891	0.000966	CcSEcCtD
Cyproterone acetate—Vomiting—Carmustine—brain cancer	0.000889	0.000964	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Etoposide—brain cancer	0.000884	0.000958	CcSEcCtD
Cyproterone acetate—Rash—Carmustine—brain cancer	0.000881	0.000956	CcSEcCtD
Cyproterone acetate—Dermatitis—Carmustine—brain cancer	0.000881	0.000955	CcSEcCtD
Cyproterone acetate—Headache—Carmustine—brain cancer	0.000876	0.00095	CcSEcCtD
Cyproterone acetate—Vomiting—Temozolomide—brain cancer	0.000859	0.000931	CcSEcCtD
Cyproterone acetate—Urticaria—Etoposide—brain cancer	0.000859	0.000931	CcSEcCtD
Cyproterone acetate—Abdominal pain—Etoposide—brain cancer	0.000855	0.000927	CcSEcCtD
Cyproterone acetate—Body temperature increased—Etoposide—brain cancer	0.000855	0.000927	CcSEcCtD
Cyproterone acetate—Rash—Temozolomide—brain cancer	0.000852	0.000924	CcSEcCtD
Cyproterone acetate—Dermatitis—Temozolomide—brain cancer	0.000851	0.000923	CcSEcCtD
Cyproterone acetate—Headache—Temozolomide—brain cancer	0.000846	0.000918	CcSEcCtD
Cyproterone acetate—Nausea—Carmustine—brain cancer	0.00083	0.0009	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—SIRT1—brain cancer	0.000803	0.0109	CbGpPWpGaD
Cyproterone acetate—Nausea—Temozolomide—brain cancer	0.000802	0.00087	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Etoposide—brain cancer	0.000796	0.000864	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CCNE1—brain cancer	0.000793	0.0108	CbGpPWpGaD
Cyproterone acetate—Asthenia—Etoposide—brain cancer	0.000776	0.000841	CcSEcCtD
Cyproterone acetate—Pruritus—Etoposide—brain cancer	0.000765	0.000829	CcSEcCtD
Cyproterone acetate—Diarrhoea—Etoposide—brain cancer	0.00074	0.000802	CcSEcCtD
Cyproterone acetate—Dizziness—Etoposide—brain cancer	0.000715	0.000775	CcSEcCtD
Cyproterone acetate—Vomiting—Etoposide—brain cancer	0.000687	0.000745	CcSEcCtD
Cyproterone acetate—Rash—Etoposide—brain cancer	0.000682	0.000739	CcSEcCtD
Cyproterone acetate—Dermatitis—Etoposide—brain cancer	0.000681	0.000738	CcSEcCtD
Cyproterone acetate—Headache—Etoposide—brain cancer	0.000677	0.000734	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000676	0.00918	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000655	0.00888	CbGpPWpGaD
Cyproterone acetate—Nausea—Etoposide—brain cancer	0.000642	0.000696	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000641	0.0087	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000636	0.00863	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CDKN2A—brain cancer	0.000628	0.00852	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	0.000622	0.00844	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—STAT3—brain cancer	0.000564	0.00765	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000541	0.00734	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—APC—brain cancer	0.000538	0.0073	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000536	0.00728	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CCND1—brain cancer	0.00053	0.0072	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000526	0.00714	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CTNNB1—brain cancer	0.000525	0.00713	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	0.000505	0.00686	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000497	0.00674	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HES1—brain cancer	0.000494	0.0067	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000483	0.00655	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000461	0.00626	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000453	0.00614	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—RELA—brain cancer	0.000447	0.00606	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000444	0.00603	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000436	0.00591	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.00043	0.00584	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.000427	0.00579	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN2A—brain cancer	0.000427	0.00579	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.000423	0.00574	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00042	0.0057	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.0004	0.00543	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000398	0.0054	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CCND1—brain cancer	0.000392	0.00532	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CTNNB1—brain cancer	0.000388	0.00527	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000381	0.00517	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000375	0.00509	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL2—brain cancer	0.00037	0.00502	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—CTNNB1—brain cancer	0.000365	0.00496	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IRS2—brain cancer	0.000363	0.00492	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—RELA—brain cancer	0.000362	0.00491	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCND1—brain cancer	0.00036	0.00489	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000357	0.00484	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	0.000342	0.00465	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000342	0.00464	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000339	0.0046	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—STAT3—brain cancer	0.000338	0.00459	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.00033	0.00447	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—brain cancer	0.000326	0.00442	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.00031	0.00421	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EGFR—brain cancer	0.000308	0.00417	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000307	0.00417	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MYC—brain cancer	0.000289	0.00392	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR2—brain cancer	0.000269	0.00365	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000257	0.00349	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000257	0.00348	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000255	0.00345	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000254	0.00345	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000248	0.00336	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000241	0.00327	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—brain cancer	0.000237	0.00322	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000224	0.00304	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000221	0.003	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000219	0.00297	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000218	0.00296	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CTNNB1—brain cancer	0.000218	0.00295	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000213	0.00289	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000211	0.00286	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—brain cancer	0.000209	0.00284	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000206	0.0028	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR2—brain cancer	0.000204	0.00277	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000201	0.00273	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH2—brain cancer	0.000193	0.00262	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000193	0.00261	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—brain cancer	0.00019	0.00257	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000188	0.00255	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2C9—brain cancer	0.000187	0.00254	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000186	0.00252	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000177	0.00241	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000173	0.00235	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000171	0.00232	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000169	0.0023	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000167	0.00227	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000165	0.00225	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BSG—brain cancer	0.000159	0.00216	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000146	0.00198	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—DNMT1—brain cancer	0.000144	0.00196	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.00014	0.0019	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—IDH1—brain cancer	0.000137	0.00186	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR2—brain cancer	0.000129	0.00176	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH2—brain cancer	0.000123	0.00166	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000111	0.00151	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—DNMT1—brain cancer	0.000109	0.00148	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ENO2—brain cancer	0.000108	0.00147	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SIRT1—brain cancer	0.000104	0.00141	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR2—brain cancer	9.82e-05	0.00133	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH2—brain cancer	9.3e-05	0.00126	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—brain cancer	8.48e-05	0.00115	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SIRT1—brain cancer	7.91e-05	0.00107	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—brain cancer	6.43e-05	0.000873	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CG—brain cancer	4.96e-05	0.000674	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—brain cancer	4.08e-05	0.000554	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—brain cancer	3.1e-05	0.00042	CbGpPWpGaD
